These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 20298317

  • 1. Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?
    McLaughlin AM, McGrath E, Barry R, Egan JJ, Gallagher CG.
    Clin Respir J; 2008 Apr; 2(2):123-6. PubMed ID: 20298317
    [Abstract] [Full Text] [Related]

  • 2. Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis.
    Slattery DM, Waltz DA, Denham B, O'Mahony M, Greally P.
    Pediatr Pulmonol; 2001 May; 31(5):383-8. PubMed ID: 11340685
    [Abstract] [Full Text] [Related]

  • 3. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

  • 4. Easy removal of a large mucus plug with a flexible paediatric bronchoscope after administration of rhDNase (Pulmozyme).
    Kamin W, Klär-Hlawatsch B, Truebel H.
    Klin Padiatr; 2006 Sep 08; 218(2):88-91. PubMed ID: 16506110
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.
    Shah PI, Bush A, Canny GJ, Colin AA, Fuchs HJ, Geddes DM, Johnson CA, Light MC, Scott SF, Tullis DE.
    Eur Respir J; 1995 Jun 08; 8(6):954-8. PubMed ID: 7589382
    [Abstract] [Full Text] [Related]

  • 6. A successful treatment of a lobar atelectasis in a patient with cystic fibrosis.
    Daccò V, Sciarrabba CS, Corti F, Rosazza C, Malfitano A, Borzani I, Colombo C.
    Pediatr Pulmonol; 2022 Nov 08; 57(11):2868-2871. PubMed ID: 36000266
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of nebulized recombinant human DNase as rescue treatment for persistent atelectasis in newborns: case-series.
    Erdeve O, Uras N, Atasay B, Arsan S.
    Croat Med J; 2007 Apr 08; 48(2):234-9. PubMed ID: 17436388
    [Abstract] [Full Text] [Related]

  • 8. [Socioeconomic evaluation of the effect of rhDNase on the cost of treating infections of the respiratory tract in patients with cystic fibrosis].
    von der Schulenburg JM, Greiner W, von der Hardt H.
    Med Klin (Munich); 1995 Apr 15; 90(4):220-4. PubMed ID: 7776934
    [Abstract] [Full Text] [Related]

  • 9. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis.
    Merkus PJ, de Hoog M, van Gent R, de Jongste JC.
    Eur Respir J; 2001 Oct 15; 18(4):734-7. PubMed ID: 11716180
    [Abstract] [Full Text] [Related]

  • 10. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
    Chen JJ, Hamilton SA.
    J Biopharm Stat; 2000 Aug 15; 10(3):287-97. PubMed ID: 10959912
    [Abstract] [Full Text] [Related]

  • 11. Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis.
    Frederiksen B, Pressler T, Hansen A, Koch C, Høiby N.
    Acta Paediatr; 2006 Sep 15; 95(9):1070-4. PubMed ID: 16938752
    [Abstract] [Full Text] [Related]

  • 12. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus.
    Durward A, Forte V, Shemie SD.
    Crit Care Med; 2000 Feb 15; 28(2):560-2. PubMed ID: 10708200
    [Abstract] [Full Text] [Related]

  • 13. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    Hubbard RC, McElvaney NG, Birrer P, Shak S, Robinson WW, Jolley C, Wu M, Chernick MS, Crystal RG.
    N Engl J Med; 1992 Mar 19; 326(12):812-5. PubMed ID: 1538726
    [No Abstract] [Full Text] [Related]

  • 14. [Recombinant human DNase in conditions other than cystic fibrosis].
    Kristensen K.
    Ugeskr Laeger; 2010 Feb 22; 172(8):616-9. PubMed ID: 20184817
    [Abstract] [Full Text] [Related]

  • 15. The use of dornase alpha for post-operative pulmonary atelectasis after congenital heart surgery.
    Ozturk E, Tanidir IC, Haydin S, Onan IS, Odemis E, Bakir I.
    Cardiol Young; 2014 Oct 22; 24(5):807-12. PubMed ID: 23915544
    [Abstract] [Full Text] [Related]

  • 16. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA, Hilton J, Jepson B, Smith L.
    Pediatrics; 2005 Oct 22; 116(4):e549-54. PubMed ID: 16147970
    [Abstract] [Full Text] [Related]

  • 17. Endotracheal DNase for atelectasis in ventilated neonates.
    MacKinnon R, Wheeler KI, Sokol J.
    J Perinatol; 2011 Dec 22; 31(12):799-801. PubMed ID: 22124516
    [Abstract] [Full Text] [Related]

  • 18. Lobar atelectasis in cystic fibrosis and treatment with recombinant human DNase I.
    Shah PL, Scott SF, Hodson ME.
    Respir Med; 1994 Apr 22; 88(4):313-5. PubMed ID: 8036296
    [No Abstract] [Full Text] [Related]

  • 19. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW, Pulmozyme Early Intervention Trial Study Group.
    J Pediatr; 2001 Dec 22; 139(6):813-20. PubMed ID: 11743506
    [Abstract] [Full Text] [Related]

  • 20. Safety of endotracheal rh DNAse (Pulmozyme) for treatment of pulmonary atelectasis in mechanically ventilated children.
    Boeuf B, Prouix F, Morneau S, Marton D, Lacroix J.
    Pediatr Pulmonol; 1998 Aug 22; 26(2):147. PubMed ID: 9727769
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.